Valuation: Yuhan Corporation

Market Cap 5,663B 4.08B 3.55B 3.36B 3.05B 5.71B 391B 5.73B 40.21B 15.52B 199B 15.31B 14.97B 640B P/E 2026 *
36.6x
P/E 2027 * 27.6x
Enterprise Value 5.57B 4.01M 3.5M 3.3M 3M 5.62M 385M 5.64M 39.57M 15.27M 196M 15.07M 14.74M 630M EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.17x
Free-Float
61.43%
Yield 2026 *
0.76%
Yield 2027 * 0.76%
1 day-2.06%
1 week-3.80%
Current month-9.32%
1 month-9.32%
3 months-4.05%
6 months-23.72%
Current year-32.47%
1 week 75,900
Extreme 75900
81,500
1 month 75,900
Extreme 75900
87,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 74 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.06%-3.80%-34.68%+5.56% 4.19B
-0.19%+2.04%+80.14%+36.22% 363B
-1.22%-1.37%+20.62%-21.54% 65.62B
+2.53%+4.90%+46.65%+187.52% 12.45B
-0.29%+2.27%-5.37%-16.54% 7.6B
-1.89%-6.83%-27.65%-14.90% 4.49B
+1.48%+2.36%-31.20%-13.91% 2.92B
-2.14%+0.86%-8.95%+48.36% 2.49B
-0.41%-0.71%-28.25%-33.78% 1.93B
-1.69%-3.90%-26.02%-19.02% 1.65B
Average -0.69%+0.23%-1.47%+15.80% 46.64B
Weighted average by Cap. -0.58%+1.36%+65.41%+29.77%

Financials

2026 *2027 *
Net sales 2,339B 1.68B 1.47B 1.39B 1.26B 2.36B 162B 2.37B 16.61B 6.41B 82.15B 6.33B 6.19B 264B 2,550B 1.84B 1.6B 1.51B 1.37B 2.57B 176B 2.58B 18.1B 6.99B 89.55B 6.9B 6.74B 288B
Net income 158B 114M 99.24M 93.71M 85.1M 159M 10.92B 160M 1.12B 433M 5.55B 428M 418M 17.87B 202B 145M 127M 120M 109M 203M 13.94B 204M 1.43B 553M 7.09B 546M 534M 22.8B
Net Debt -89.35B -64.32M -56.09M -52.96M -48.09M -90.1M -6.17B -90.48M -634M -245M -3.14B -242M -236M -10.1B -133B -95.61M -83.37M -78.72M -71.49M -134M -9.17B -134M -943M -364M -4.66B -359M -351M -15.01B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
18/09/26 75,900.00 -2.06% 514,417
17/09/26 ₩77,500.00 +0.26% 140,552
16/09/26 ₩77,300.00 -2.52% 155,292
15/09/26 ₩79,300.00 +0.25% 217,062
14/09/26 ₩79,100.00 -0.38% 145,503
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
75,900.00KRW
Average target price
113,875.00KRW
Spread / Average Target
+50.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!